Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Clinical trial NCT05774639 · COMPLETED
Trial details
- NCT number
- NCT05774639
- Sponsor
- Kashiv BioSciences, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2024-10-03
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.